Metoprolol Tartrate NDC 51662-1365

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1365Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1365Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1365-1	51662136501	5 mL in 1 VIAL (51662-1365-1)Marketed from Dec 8, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoprolol Tartrate
Generic name (nonproprietary): metoprolol tartrate
Active ingredients: Metoprolol tartrate — 5 mg/5mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091045
Marketing start: Dec 8, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 51662-1365_ef7bd5a0-02a7-7b66-e053-2995a90a8ffaSPL ID ef7bd5a0-02a7-7b66-e053-2995a90a8ffaSPL set ID 993c3a0d-5472-3de3-e053-2995a90acdf6RxCUI 866508UNII W5S57Y3A5L
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662136501 followed by a unit qualifier and the quantity

Package 51662-1365-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2022.

Indications (excerpt from the label)

INDICATIONS & USAGE Myocardial Infarction Metoprolol tartrate injection is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Treatment with intravenous metoprolol tartrate injection can be initiated as soon as the patient’s clinical condition allows (see DOSAGE & ADMINISTRATION , CONTRAINDICATIONS , and WARNINGS ). Alternatively, treatment can begin within 3 to 10 days of the acute event (see DOSAGE & ADMINISTRATION ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091045

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091045
Product	Strength	Form · route	Labeler	Product NDC
Metoprololmetoprolol tartrate	Metoprolol tartrate 5 mg/5mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-660
Metoprololmetoprolol tartrate	Metoprolol tartrate 5 mg/5mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-665